VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $263,022,000 | -50.4% | 18,114,432 | -16.1% | 4.45% | -54.6% |
| Q3 2016 | $530,062,000 | +21.9% | 21,591,122 | 0.0% | 9.79% | +69.2% |
| Q2 2016 | $434,845,000 | -23.4% | 21,591,122 | 0.0% | 5.79% | -9.8% |
| Q1 2016 | $567,847,000 | -66.3% | 21,591,122 | +30.1% | 6.41% | -52.6% |
| Q4 2015 | $1,686,488,000 | -51.5% | 16,591,122 | -14.8% | 13.54% | -45.6% |
| Q3 2015 | $3,473,760,000 | -19.7% | 19,473,933 | 0.0% | 24.90% | -16.8% |
| Q2 2015 | $4,326,134,000 | +11.8% | 19,473,933 | 0.0% | 29.95% | +15.9% |
| Q1 2015 | $3,867,913,000 | – | 19,473,933 | – | 25.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |